Increased serum lactate
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Elevated hepatic transaminase
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Microvesicular hepatic steatosis
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Dicarboxylic aciduria
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Generalized hypotonia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Nonketotic hypoglycemia
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Decreased activity of mitochondrial complex I
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Steatohepatitis
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
EMG: myopathic abnormalities
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Elevated creatine kinase after exercise
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Elevated plasma acylcarnitine levels
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Increased lactate dehydrogenase activity
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Generalized Muscle Weakness, CTCAE
|
0.100 |
Biomarker
|
phenotype |
HPO |
|
|
|
Mitochondrial Encephalomyopathies
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Mitochondrial encephalomyopathy due to a novel mutation in ACAD9.
|
23836383 |
2013 |
Cardiomyopathies
|
0.030 |
GeneticVariation
|
group |
BEFREE |
ACAD9 is an acyl-CoA dehydrogenase with a novel function in assembly of complex I; biallelic mutations cause progressive encephalomyopathy, recurrent Reye syndrome, and fatal cardiomyopathy.
|
26826406 |
2016 |
nervous system disorder
|
0.010 |
Biomarker
|
group |
BEFREE |
ACAD9-mutated patients have been reported to suffer from primarily heart, muscle, liver, and nervous system disorders.
|
27233227 |
2016 |
Nicotinamide adenine dinucleotide coenzyme Q reductase deficiency
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
ACAD9 mutation is suspected in cases of elevated lactic acid levels combined with complex I deficiency, and confirmed by ACAD9 gene analysis.
|
27233227 |
2016 |
Nicotinamide adenine dinucleotide coenzyme Q reductase deficiency
|
0.090 |
GeneticVariation
|
disease |
BEFREE |
ACAD9 is an assembly factor for the mitochondrial respiratory chain complex I. ACAD9 mutations are recognized as frequent causes of complex I deficiency.
|
28279569 |
2017 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
A Comprehensive Genomic Analysis Reveals the Genetic Landscape of Mitochondrial Respiratory Chain Complex Deficiencies.
|
26741492 |
2016 |
Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of
|
0.610 |
Biomarker
|
disease |
CLINGEN |
A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency.
|
17564966 |
2007 |
Acyl-CoA Dehydrogenase Family, Member 9, Deficiency of
|
0.610 |
GermlineCausalMutation
|
disease |
ORPHANET |
A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency.
|
17564966 |
2007 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency.
|
17564966 |
2007 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency.
|
17564966 |
2007 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20
|
0.600 |
Biomarker
|
disease |
GENOMICS_ENGLAND |
A new genetic disorder in mitochondrial fatty acid beta-oxidation: ACAD9 deficiency.
|
17564966 |
2007 |
MITOCHONDRIAL COMPLEX I DEFICIENCY, NUCLEAR TYPE 20
|
0.600 |
GeneticVariation
|
disease |
UNIPROT |
A Patient with Complex I Deficiency Caused by a Novel ACAD9 Mutation Not Responding to Riboflavin Treatment.
|
23996478 |
2014 |